APOE and Alzheimer disease: In opposition to prevailing beliefs, males and females with the APOE ε3/ε4 genotype exhibit nearly equivalent likelihoods of developing AD between the ages of 55 and 85 years, but females exhibit a heightened risk at younger ages.7